WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2017055397) METABOLOMIC SIGNATURE OF DIAGNOSIS AND DISEASE PROGRESSION IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2017/055397    International Application No.:    PCT/EP2016/073183
Publication Date: 06.04.2017 International Filing Date: 29.09.2016
IPC:
G01N 33/68 (2006.01), G01N 33/92 (2006.01)
Applicants: ONE WAY LIVER, S.L. [ES/ES]; Parque Tecnológico de Bizkaia Edificio 502, Planta 0 48160 Derio-Bizkaia (ES).
VIRGINIA COMMONWEALTH UNIVERSITY [--/US]; 800 E Leigh St., Suite 3000 Richmond, 23298 (US)
Inventors: ALONSO SÁNCHEZ, Cristina; (ES).
MARTÍNEZ ARRANZ, Ibon; (ES).
MATO DE LA PAZ, José María; (ES).
SANYAL, Arun J; (US)
Agent: VÁZQUEZ VÁZQUEZ, Irene; (ES)
Priority Data:
15382477.6 30.09.2015 EP
Title (EN) METABOLOMIC SIGNATURE OF DIAGNOSIS AND DISEASE PROGRESSION IN NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
(FR) SIGNATURE MÉTABOLOMIQUE DE DIAGNOSTIC ET DE PROGRESSION DE MALADIE DE STÉATOSE HÉPATIQUE NON ALCOOLIQUE (NAFLD)
Abstract: front page image
(EN)The present invention is directed to a diagnostic method for non-alcoholic fatty liver disease (NAFLD) and to a method for monitoring the progression of the disease based on the determination of the levels of different metabolites. The invention also provides a method for determining the efficacy of an NAFLD therapy and a method for identification of compounds suitable for the treatment of NAFLD.
(FR)La présente invention concerne un procédé de diagnostic de stéatose hépatique non-alcoolique (NAFLD) et un procédé pour surveiller la progression de la maladie sur la base de la détermination des niveaux de différents métabolites. L'invention concerne également un procédé pour déterminer l'efficacité d'une thérapie de NAFLD et un procédé d'identification de composés appropriés pour le traitement de NAFLD.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JP, KE, KG, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)